Europe Transient Protein Expression Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Transient Protein Expression Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Transient Protein Expression Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Transient Protein Expression Market Regional Analysis

6.2 Europe Transient Protein Expression Market Revenue 2021-2031 (US$ Million)

6.3 Europe Transient Protein Expression Market Forecast Analysis

7. Europe Transient Protein Expression Market Analysis – by Product Type

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Reagents

7.2.1 Overview
7.2.2 Reagents: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Expression Vectors

7.3.1 Overview
7.3.2 Expression Vectors: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Competent Cells

7.4.1 Overview
7.4.2 Competent Cells: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Transient Protein Expression Market Analysis – by Application

8.1 Genomic Research

8.1.1 Overview
8.1.2 Genomic Research: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Gene Therapy

8.2.1 Overview
8.2.2 Gene Therapy: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Bio production

8.3.1 Overview
8.3.2 Bio production: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Cancer Research

8.4.1 Overview
8.4.2 Cancer Research: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Drug Development

8.5.1 Overview
8.5.2 Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Transient Protein Expression Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Academic and Research Institutes

9.2.1 Overview
9.2.2 Academic and Research Institutes: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Clinical Research Organizations

9.3.1 Overview
9.3.2 Clinical Research Organizations: Europe Transient Protein Expression Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Transient Protein Expression Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Transient Protein Expression Market Breakdown, by Key Country, 2024 and 2031 (%)
10.2.1.1 Europe Transient Protein Expression Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.1.1 UK: Europe Transient Protein Expression Market Breakdown, by Product Type
10.2.1.1.2 UK: Europe Transient Protein Expression Market Breakdown, by Application
10.2.1.1.3 UK: Europe Transient Protein Expression Market Breakdown, by End User

10.2.1.2 Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.2.1 Germany: Europe Transient Protein Expression Market Breakdown, by Product Type
10.2.1.2.2 Germany: Europe Transient Protein Expression Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Transient Protein Expression Market Breakdown, by End User

10.2.1.3 France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.3.1 France: Europe Transient Protein Expression Market Breakdown, by Product Type
10.2.1.3.2 France: Europe Transient Protein Expression Market Breakdown, by Application
10.2.1.3.3 France: Europe Transient Protein Expression Market Breakdown, by End User

10.2.1.4 Russia: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.4.1 Russia: Europe Transient Protein Expression Market Breakdown, by Product Type
10.2.1.4.2 Russia: Europe Transient Protein Expression Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Transient Protein Expression Market Breakdown, by End User

10.2.1.5 Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.5.1 Italy: Europe Transient Protein Expression Market Breakdown, by Product Type
10.2.1.5.2 Italy: Europe Transient Protein Expression Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Transient Protein Expression Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by Product Type
10.2.1.6.2 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Transient Protein Expression Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Merck KGaA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 QIAGEN NV

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 GenScript Biotech Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Promega Corp

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Takara Bio Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 New England Biolabs

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Agilent Technologies Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Mirus Bio LLC

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Bio-Rad Laboratories Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Lonza Group AG

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 MaxCyte Inc

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Transient Protein Expression Market